• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic Relevance of Lymphatic Vessel Density in Squamous Cell Carcinomas of the Oral Cavity: A Systematic Review and Meta-Analysis.口腔鳞状细胞癌中淋巴管密度的预后相关性:系统评价和荟萃分析。
Head Neck Pathol. 2022 Dec;16(4):1185-1194. doi: 10.1007/s12105-022-01474-1. Epub 2022 Jul 29.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.临床评估用于检测貌似健康的成年人的口腔癌和潜在恶性疾病。
Cochrane Database Syst Rev. 2021 Dec 10;12(12):CD010173. doi: 10.1002/14651858.CD010173.pub3.
6
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.职业性HIV暴露后的抗逆转录病毒暴露后预防(PEP)。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3.
7
miRNA for the assessment of lymph node metastasis in patients with oral squamous cell carcinoma: Systematic review and metanalysis.miRNA 用于评估口腔鳞状细胞癌患者的淋巴结转移:系统评价和荟萃分析。
J Oral Pathol Med. 2021 Apr;50(4):345-352. doi: 10.1111/jop.13134. Epub 2021 Jan 7.
8
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
9
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Correlation between Histopathological Features and Clinical Outcomes in Patients with Oral Squamous Cell Carcinoma.口腔鳞状细胞癌患者组织病理学特征与临床结局的相关性
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S433-S435. doi: 10.4103/jpbs.jpbs_1442_24. Epub 2025 Feb 25.
2
Lymphatic Vascular Density, the Expression of Podoplanin and Tumor Budding in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌中的淋巴管密度、Podoplanin 表达和肿瘤芽。
Head Neck Pathol. 2023 Jun;17(2):371-382. doi: 10.1007/s12105-022-01511-z. Epub 2022 Dec 8.
3
Comprehensive Analysis of the Role of on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.在头颈部鳞状细胞癌中对预后和免疫浸润作用的综合分析。
Anal Cell Pathol (Amst). 2022 Sep 19;2022:2371057. doi: 10.1155/2022/2371057. eCollection 2022.

本文引用的文献

1
Oral cancer in India, a growing problem: Is limiting the exposure to avoidable risk factors the only way to reduce the disease burden?印度口腔癌问题日益严重:限制可避免的风险因素暴露是否是减轻疾病负担的唯一途径?
Oral Oncol. 2022 Feb;125:105677. doi: 10.1016/j.oraloncology.2021.105677. Epub 2021 Dec 24.
2
Intratumoral lymphatic vascular density is an independent factor for disease-free and overall survival in advanced stage oral squamous cell carcinoma.肿瘤内淋巴管密度是晚期口腔鳞状细胞癌无病生存和总生存的独立因素。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Nov;132(5):580-588. doi: 10.1016/j.oooo.2021.07.014. Epub 2021 Jul 21.
3
Association of lymph vessel density with occult lymph node metastasis and prognosis in oral squamous cell carcinoma.淋巴管密度与口腔鳞状细胞癌隐匿性淋巴结转移及预后的关系。
BMC Oral Health. 2021 Mar 11;21(1):114. doi: 10.1186/s12903-021-01459-6.
4
Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.口腔鳞状细胞癌中淋巴管密度的预后价值。
Life Sci. 2021 Jan 15;265:118746. doi: 10.1016/j.lfs.2020.118746. Epub 2020 Nov 9.
5
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.表达谱分析确定IER3可预测舌癌的总生存期并促进淋巴结转移。
Cancer Cell Int. 2019 Nov 21;19:307. doi: 10.1186/s12935-019-1028-2. eCollection 2019.
6
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
7
Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌中的淋巴管生成与淋巴结转移
Anticancer Res. 2018 Nov;38(11):6157-6162. doi: 10.21873/anticanres.12968.
8
Quantifying publication bias in meta-analysis.量化荟萃分析中的发表偏倚。
Biometrics. 2018 Sep;74(3):785-794. doi: 10.1111/biom.12817. Epub 2017 Nov 15.
9
High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer.高淋巴管密度和淋巴管浸润均提示乳腺癌预后不良。
BMC Cancer. 2017 May 17;17(1):335. doi: 10.1186/s12885-017-3338-x.
10
The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012.2012 年全球唇、口腔和咽癌的亚部位发病情况。
CA Cancer J Clin. 2017 Jan;67(1):51-64. doi: 10.3322/caac.21384. Epub 2016 Oct 19.

口腔鳞状细胞癌中淋巴管密度的预后相关性:系统评价和荟萃分析。

Prognostic Relevance of Lymphatic Vessel Density in Squamous Cell Carcinomas of the Oral Cavity: A Systematic Review and Meta-Analysis.

机构信息

Department of Oral Pathology, Microbiology, and Forensic Odontology, Dental Institute, RIMS, Ranchi, India.

Department of Anatomy, RIMS, Ranchi, India.

出版信息

Head Neck Pathol. 2022 Dec;16(4):1185-1194. doi: 10.1007/s12105-022-01474-1. Epub 2022 Jul 29.

DOI:10.1007/s12105-022-01474-1
PMID:35904748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9729525/
Abstract

BACKGROUND

Oral Squamous Cell Carcinoma (OSCC), a major debilitating illness demands focus in recent times due to a constant upsurge in cases and poor prognostic implications. An urgent mandate upon finding evidence of relevant prognostic markers is the need of the hour. This systematic review and meta-analysis, therefore, elect an objective assessment of Lymphatic Vessel Density (LVD) as a pertinent parameter governing OSCC prognosis.

METHODS

The study protocol was registered at the International Prospective Register Of Systematic Reviews (PROSPERO). Databases were searched using the MeSH keywords for all study types following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The exposure under consideration was the evaluation of LVD in patients of OSCC. The outcome was measured as pooled Hazard/Odd's/Risk ratios in survived versus non-survived OSCC population. The risk of bias assessment was performed using the QUIPS tool. Heterogeneity was assessed by Chi-square and I statistics whereas publication bias was investigated using Egger's test of significance. All the statistical analysis was conducted using STATA version 13.0.

RESULTS

The initial search of 226 records were screened and filtered through the inclusion and exclusion criteria to achieve an outcome of 15 studies for qualitative synthesis out of which seven studies were eligible for meta-analysis. Pooled Hazard of enhanced Lymphatic Vessel Density was not found to be statistically significant (HR = 1.98, p = 0.553); contrary to the pooled Odd's/Risk for patient survival which was statistically significant (RR = 1.33, p = 0.046). The I test of heterogeneity was also significant (58.8%, p = 0.046).

CONCLUSIONS

This meta-analysis helps to generate pathfinding evidence for a noteworthy role of Lymphatic Vessel Density evaluation in suggesting OSCC prognosis.

摘要

背景

口腔鳞状细胞癌(OSCC)是一种主要的使人虚弱的疾病,由于病例不断增加和预后不良的影响,最近受到了关注。当发现相关预后标志物的证据时,迫切需要进行客观评估。因此,本系统评价和荟萃分析选择评估淋巴管密度(LVD)作为预测 OSCC 预后的相关参数。

方法

该研究方案在国际前瞻性系统评价注册库(PROSPERO)中进行了注册。根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,使用 MeSH 关键词搜索了所有研究类型的数据库。考虑的暴露因素是评估 OSCC 患者的 LVD。结局是在 OSCC 存活与非存活人群中测量的汇总风险比/优势比/风险比。使用 QUIPS 工具进行偏倚风险评估。使用 Chi-square 和 I 统计量评估异质性,使用 Egger 检验评估发表偏倚。所有统计分析均使用 STATA 版本 13.0 进行。

结果

最初搜索了 226 条记录,通过纳入和排除标准进行筛选和过滤,得出 15 项研究进行定性综合分析,其中 7 项研究符合荟萃分析的条件。增强的淋巴管密度的汇总风险没有显示出统计学意义(HR=1.98,p=0.553);相反,患者生存的汇总优势/风险比具有统计学意义(RR=1.33,p=0.046)。异质性 I 检验也具有统计学意义(58.8%,p=0.046)。

结论

这项荟萃分析有助于为淋巴管密度评估在提示 OSCC 预后方面的重要作用提供开创性的证据。